NCT05804812 is a NA clinical trial of laughter therapy in Migraine, sponsored by Sinop University.

Who is sponsoring NCT05804812?

NCT05804812 is sponsored by Sinop University.

What drugs are being tested in NCT05804812?

Interventions in NCT05804812: laughter therapy.

What condition does NCT05804812 study?

NCT05804812 studies Migraine, Laughter.

Is NCT05804812 still recruiting?

NCT05804812 is currently completed. Last updated 7 July 2023.

Last reviewed 2023-07-07 · How we verify

NCT05804812

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Laughter Therapy in Women

Completed NA Last updated 7 July 2023

What this trial tests

NA trial testing laughter therapy in Migraine in 53 participants. Completed in 28 June 2023.

Timeline

6 April 2023

Primary endpoint
25 May 2023

28 June 2023

Quick facts

Lead sponsor	Sinop University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	53
Start date	6 April 2023
Primary completion	25 May 2023
Estimated completion	28 June 2023
Sites	2 locations across Turkey (Türkiye)

Drugs / interventions tested

laughter therapy

Conditions studied

Migraine — all drugs for Migraine →
Laughter — all drugs for Laughter →

Sponsor

Sinop University

Who can join

Adults 18 to 30, female only, with Migraine or Laughter. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Migraine: An episodic disorder consisting of severe headache, usually with photophobia (sensitivity to light), phonophobia (sensitivity to sound), and/or nausea (occasionally vomiting). Migraine is predominantly a female disease. The incidence of migraine was found to in women (18.2/1000 person-years) and between the ages of 15-19 in men (6.2/1000 person-years). The incidence of migraine was found to peak between the ages of 20-24 in women (18.2/1000 person-years) and between the ages of 15-19 in men (6.2/1000 person-years). Migraine treatments are generally classified as pharmacological (treatment with medication) and non-pharmacological (treatment with no medication). Laughter therapy has recently come to the fore as a non-pharmacological and alternative treatment in chronic pain management. In a randomized controlled study, 30 minutes of laughter therapy was applied to women on the 2nd and 6th days after mastectomy surgery and it was determined that women who received laughter therapy had a significant decrease in pain and anxiety levels. This study was planned to determine the effect of laughter therapy on women with migraine.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of laughter therapy

Trials testing the same drug.

NCT07020962 — Effect of Laughter Therapy on Breast Cancer Patients · NA · not yet recruiting
NCT06283810 — The Effects of Interpersonal Relationship Psychotherapy and Laughter Therapy · NA · completed
NCT05806541 — The Effect Of Laughter Therapy On Self-Efficacy · NA · completed
NCT05807698 — The Effect of Laughter Yoga on Psychological Well-Being · NA · unknown
NCT05807685 — The Effect Of Laughter Therapy On Burnout And Guılt In Women · NA · unknown

Other recruiting trials for Migraine

Currently open trials in the same condition.

NCT07419607 — MIGRAFIT: Evaluating a Group Therapy Program Combining Physical Activity, Progressive Muscle Relaxation and Psychoeducat · NA · recruiting
NCT07487701 — Migraine Prevention With the Remote Electrical Neuromodulation (REN) Wearable: A Real-world Evidence Study · NA · active not recruiting
NCT07343427 — Impact of GON PRF on Central Sensitization in Migraine Patients · NA · active not recruiting
NCT07336056 — Nerivio Efficacy Under High-Frequency Use · Phase 4 · active not recruiting
NCT07385755 — Desvenlafaxine for Preventive Treatment of Frequent Migraines · NA · active not recruiting

Other Sinop University trials

Trials by the same sponsor.

NCT07526415 — Effect of Recording Duration on Heart Rate Variability During taVNS · NA · not yet recruiting
NCT07531992 — Comparison of Heart Rate Variability Analysis Durations and Their Relationship With Blood Pressure · NA · not yet recruiting
NCT07532005 — Non-Invasive Transcutaneous Auricular Vagus Nerve Stimulation Applied at Different Durations in Healthy Adults · NA · not yet recruiting
NCT07526402 — Different Frequency Applications of Transcutaneous Auricular Vagus Nerve Stimulation in Healthy Individuals · NA · not yet recruiting
NCT07392112 — Nada Yoga Music Therapy for Pain and Anxiety in Labor · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05804812 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sinop University
Last refreshed: 7 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05804812.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing